Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 3
2014 2
2016 1
2017 3
2018 2
2022 1
2023 3
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Comparative safety and effectiveness of TNF inhibitors, IL6 inhibitors and methotrexate for the treatment of immune checkpoint inhibitor-associated arthritis.
Bass AR, Abdel-Wahab N, Reid PD, Sparks JA, Calabrese C, Jannat-Khah DP, Ghosh N, Rajesh D, Aude CA, Gedmintas L, MacFarlane L, Arabelovic S, Falohun A, Mushtaq K, Haj FA, Diab A, Shah AA, Bingham CO, Chan KK, Cappelli LC. Bass AR, et al. Among authors: gedmintas l. Ann Rheum Dis. 2023 Jul;82(7):920-926. doi: 10.1136/ard-2023-223885. Epub 2023 Apr 5. Ann Rheum Dis. 2023. PMID: 37019614 Free PMC article.
Mortality and immune-related adverse events after immune checkpoint inhibitor initiation for cancer among patients with pre-existing rheumatoid arthritis: a retrospective, comparative, cohort study.
McCarter KR, Wolfgang T, Arabelovic S, Wang X, Yoshida K, Banasiak EP, Qian G, Kowalski EN, Vanni KMM, LeBoeuf NR, Buchbinder EI, Gedmintas L, MacFarlane LA, Rao DA, Shadick NA, Gravallese EM, Sparks JA. McCarter KR, et al. Among authors: gedmintas l. Lancet Rheumatol. 2023 May;5(5):e274-e283. doi: 10.1016/s2665-9913(23)00064-4. Epub 2023 Mar 27. Lancet Rheumatol. 2023. PMID: 37841635 Free PMC article.
Levamisole-induced retiform purpura.
Click J, Gee S, Cortes R, Gedmintas L, Merola JF, Bykerk V, Saveedra A. Click J, et al. Among authors: gedmintas l. J Drugs Dermatol. 2011 Feb;10(2):217. J Drugs Dermatol. 2011. PMID: 21361080 No abstract available.
Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer.
McCarter KR, Arabelovic S, Wang X, Wolfgang T, Yoshida K, Qian G, Kowalski EN, Vanni KMM, LeBoeuf NR, Buchbinder EI, Gedmintas L, MacFarlane LA, Rao DA, Shadick NA, Gravallese EM, Sparks JA. McCarter KR, et al. Among authors: gedmintas l. Semin Arthritis Rheum. 2024 Feb;64:152335. doi: 10.1016/j.semarthrit.2023.152335. Epub 2023 Dec 8. Semin Arthritis Rheum. 2024. PMID: 38100899
Rheumatologic symptoms in oncologic patients on PD-1 inhibitors.
Kuswanto WF, MacFarlane LA, Gedmintas L, Mulloy A, Choueiri TK, Bermas BL. Kuswanto WF, et al. Among authors: gedmintas l. Semin Arthritis Rheum. 2018 Jun;47(6):907-910. doi: 10.1016/j.semarthrit.2017.10.018. Epub 2017 Oct 31. Semin Arthritis Rheum. 2018. PMID: 29191375
Predictors of Rheumatic Immune-Related Adverse Events and De Novo Inflammatory Arthritis After Immune Checkpoint Inhibitor Treatment for Cancer.
Cunningham-Bussel A, Wang J, Prisco LC, Martin LW, Vanni KMM, Zaccardelli A, Nasrallah M, Gedmintas L, MacFarlane LA, Shadick NA, Awad MM, Rahma O, LeBoeuf NR, Gravallese EM, Sparks JA. Cunningham-Bussel A, et al. Among authors: gedmintas l. Arthritis Rheumatol. 2022 Mar;74(3):527-540. doi: 10.1002/art.41949. Epub 2022 Jan 25. Arthritis Rheumatol. 2022. PMID: 34397169 Free PMC article.
14 results